MedTrace Logo

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

NCT05006677 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2023-03-02

No results posted yet for this study

Summary

To observe the effectiveness and safety of different therapies-non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) or antiplatelet agents and non-antithrombotic therapy - for the treatment of VT.

Conditions

  • Ventricular Thrombus

Interventions

DRUG

non-vitamin K antagonist oral anticoagulants (NOACs)

Collecting information of patients with VT who received NOACs

DRUG

vitamin K antagonists (VKAs)

Collecting information of patients with VT who received VKAs

DRUG

antiplatelet agents

Collecting information of patients with VT who received antiplatelet agents

OTHER

non-antithrombotic therapy

Collecting information of patients with VT without any antithrombotic therapy

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2023-10-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006677 on ClinicalTrials.gov